Web Date: September 21, 2011
Fast, Reliable Tool Characterizes Antibodies
Small molecules aren’t the only tools drug makers have to target the protein culprits of disease. Antibodies can bind these unruly proteins, to either shut them down or to recruit the body’s immune system to attack the diseased cells. As a result, chemists have turned to so-called therapeutic antibodies more and more to treat diseases such as autoimmune disorders and cancer. Now researchers report a method using mass spectrometry to help drug developers rapidly and . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society